1
/
of
1
Elabscience
SKU:PKSH033270
Recombinant Human β-NGF/NGFB Protein (aa 122-23, Human Cells)(Active)
Recombinant Human β-NGF/NGFB Protein (aa 122-23, Human Cells)(Active)
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human β-NGF/NGFB Protein (AA 122-23, Human Cells)(Active), a cutting-edge product that revolutionizes the field of biotechnology. This meticulously engineered protein is derived from human cells, ensuring utmost authenticity and efficacy.
The Recombinant Human β-NGF/NGFB Protein (AA 122-23, Human Cells)(Active) is a potent and active substance that holds immense potential in various scientific and medical applications. With its precise amino acid sequence spanning from 122 to 23, this protein exhibits remarkable biological activity, making it an invaluable tool for researchers and practitioners alike.
This product is meticulously manufactured using state-of-the-art techniques, guaranteeing the highest level of purity and quality. Its active nature enables it to interact with specific receptors, triggering a cascade of cellular responses that contribute to the advancement of scientific knowledge and therapeutic interventions.
The Recombinant Human β-NGF/NGFB Protein (AA 122-23, Human Cells)(Active) holds immense promise in the fields of neuroscience, regenerative medicine, and drug development. Its ability to stimulate neuronal growth and survival makes it an indispensable asset in the study and treatment of neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases.
Furthermore, this protein's potential extends beyond the realm of neuroscience. Its multifaceted properties have been harnessed in wound healing, tissue regeneration, and immune modulation, offering a wide range of possibilities for medical breakthroughs.
In conclusion, the Recombinant Human β-NGF/NGFB Protein (AA 122-23, Human Cells)(Active) represents a groundbreaking advancement in biotechnology. Its meticulously engineered composition, derived from human cells, ensures unparalleled authenticity and efficacy. With its remarkable biological activity and potential applications in various scientific and medical fields, this product is poised to revolutionize research and therapeutic interventions.
The Recombinant Human β-NGF/NGFB Protein (AA 122-23, Human Cells)(Active) is a potent and active substance that holds immense potential in various scientific and medical applications. With its precise amino acid sequence spanning from 122 to 23, this protein exhibits remarkable biological activity, making it an invaluable tool for researchers and practitioners alike.
This product is meticulously manufactured using state-of-the-art techniques, guaranteeing the highest level of purity and quality. Its active nature enables it to interact with specific receptors, triggering a cascade of cellular responses that contribute to the advancement of scientific knowledge and therapeutic interventions.
The Recombinant Human β-NGF/NGFB Protein (AA 122-23, Human Cells)(Active) holds immense promise in the fields of neuroscience, regenerative medicine, and drug development. Its ability to stimulate neuronal growth and survival makes it an indispensable asset in the study and treatment of neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases.
Furthermore, this protein's potential extends beyond the realm of neuroscience. Its multifaceted properties have been harnessed in wound healing, tissue regeneration, and immune modulation, offering a wide range of possibilities for medical breakthroughs.
In conclusion, the Recombinant Human β-NGF/NGFB Protein (AA 122-23, Human Cells)(Active) represents a groundbreaking advancement in biotechnology. Its meticulously engineered composition, derived from human cells, ensures unparalleled authenticity and efficacy. With its remarkable biological activity and potential applications in various scientific and medical fields, this product is poised to revolutionize research and therapeutic interventions.
Share
